SRI International Announces Collaboration Agreement with Janssen

MENLO PARK, Calif.: MENLO PARK, Calif., Jan. 5, 2022 /PRNewswire/ -- SRI International (SRI) today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Under the terms of the agreement, the organizations and their scientists...

Click to view original post